Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeName |
gptkb:basimglurant
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:Seaside_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
STX-101
|
| gptkbp:intendedUse |
treatment of Fragile X syndrome
|
| gptkbp:mechanismOfAction |
mGluR5 antagonist
|
| gptkbp:status |
development discontinued
|
| gptkbp:target |
metabotropic glutamate receptor 5
|
| gptkbp:bfsParent |
gptkb:Scorpion_Therapeutics
|
| gptkbp:bfsLayer |
7
|